Breast cancer, ovarian cancer, and other female cancers
Menopause and hormone therapy
Osteoporosis
Pregnancy and childbirth
Sexual health
Pelvic floor disorders and Polycystic ovary syndrome
Benign conditions affecting the function of the female reproductive organ
Mental health issues are common but underdiagnosed and underreported
Gender differences occur particularly in the rates of common mental disorders - depression, anxiety and somatic complaints
These disorders, in which women predominate, affect approximately 1 in 3 people in the community and constitute a serious public health problem
Mental health issues that affect women more than men
Unipolar depression
Depressive disorders
Depression
Anxiety
Psychological distress
Sexual violence
Domestic violence
Substance use
Vitamin D deficiency
Serum 25-hydroxyvitamin D level of less than 20 ng per mL (50 nmol per L)
Vitamin D insufficiency
Serum 25-hydroxyvitamin D level of 20 to 30 ng per mL (50 to 75 nmol per L)
A 25-hydroxyvitamin D level should be obtained in patients with suspected vitamin D deficiency
Vitamin D deficiency affects all ages
Vitamin D deficiency is more common in females (37.3%) than males (5.1%)
Causes of vitamin D deficiency
Malnutrition
Obesity
Anorexia/bulimia
Common manifestations of vitamin D deficiency
Low back pain
Proximal muscle weakness
Muscle aches
Throbbing bone pain elicited with pressure over the sternum or tibia
Goal of vitamin D deficiency treatment
To normalize vitamin D levels to relieve symptoms and decrease the risk of fractures, falls, and other adverse health outcomes
Vitamin D deficiency treatment
1. Oral ergocalciferol (vitamin D2) at 50,000 IU per week for eight weeks
2. After vitamin D levels normalize, cholecalciferol (vitamin D3) at 800 to 1,000 IU per day from dietary and supplemental sources
The American Academy of Pediatrics recommends that infants and children receive at least 400 IU per day from diet and supplements
Evidence shows that vitamin D supplementation of at least 700 to 800 IU per day reduces fracture and fall rates in adults
Obesity rates are higher in Jordanian females (53.1%) compared to males (28.1%)
Breast cancer is the most lethal cancer for women ages 20-59 throughout the world
Breast cancer is increasing among women in developing countries where it is often diagnosed at too late a stage to receive effective medical treatment
Breast cancer survival rates vary greatly worldwide, ranging from 80% or over in North America, Sweden and Japan to around 60% in middle-income countries and below 40% in low-income countries
Cervical cancer
A cancer arising from the cervix due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body
Nearly all cases of cervical cancer can be attributable to certain types of HPV infection
Two HPV types (16 and 18) cause 70% of cervical cancers and precancerous cervical lesions
HPV is mainly transmitted through sexual contact and most people are infected with HPV shortly after the onset of sexual activity
It takes 15 to 20 years for cervical cancer to develop in women with normal immune systems, and only 5 to 10 years in women with weakened immune systems, such as those with untreated HIV infection
In developed countries, programmes are in place which enable women to get screened, making most pre-cancerous lesions identifiable at stages when they can easily be treated, preventing up to 80% of cervical cancers
In developing countries, limited access to effective screening means that the disease is often not identified until it is further advanced and symptoms develop, resulting in a higher rate of death from cervical cancer
Symptoms of cervical cancer
Irregular, intermenstrual (between periods) or abnormal vaginal bleeding after sexual intercourse
Back, leg or pelvic pain
Fatigue, weight loss, loss of appetite
Vaginal discomfort or odorous discharge
Screening for cervical cancer
Cervical cytology alone every 3 years
High-risk HPV testing every 5 years
Co-testing with cervical cytology and high-risk HPV testing every 5 years
Maternal mortality
Deaths due to complications from pregnancy or childbirth
From 2000 to 2017, the global maternal mortality ratio declined by 38 per cent – from 342 deaths to 211 deaths per 100,000 live births
Ninety-nine percent of these deaths occur in the developing world
Maternal mortality is higher in women living in rural areas and among poorer communities
Young adolescents face a higher risk of complications and death as a result of pregnancy than other women
Maternal mortality in Jordan decreased from 110/100,000 in 1990 to 58/100,000 in 2015
Between 2000 and 2017, South Asia achieved the greatest overall percentage reduction in maternal mortality ratio, with a reduction of 59 per cent (from 395 to 163 maternal deaths per 100,000 live births)
Sub-Saharan Africa achieved a substantial reduction of 39 per cent of maternal mortality during this period
Causes of maternal death
Hemorrhage (27%)
Hypertension (14%)
Sepsis (11%)
Abortion (8%)
Embolism (3%)
Infection, anaemia, HIV/AIDS, and cardiovascular disease
Polycystic ovary syndrome (PCOS)
Consists of the clinical findings of ovulatory dysfunction, hyperandrogenism, and polycystic ovaries